Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Caffeine Withdrawal

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Caffeine Withdrawal

Karima R. Sajadi-Ernazarova et al.
Free Books & Documents

Excerpt

Caffeine is a central nervous system (CNS) stimulant of the methylxanthine class and is one of the most widely used drugs in the world. Unlike other psychoactive drugs, it is legal, cheap, and not regulated in almost all parts of the world. Individuals who habitually drink caffeine-contained beverages may develop a physical, emotional, and psychological dependence on it and may experience a caffeine withdrawal syndrome after abrupt cessation of caffeine intake. Multiple studies have demonstrated that caffeine-withdrawal syndrome is a clinically relevant entity and is included in the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM–5; American Psychiatric Association, 2013).

Physicians working in the emergency departments (ED) and the hospital must be familiar with this syndrome when they encounter patients with relevant symptoms, as they overlap with symptoms such as anxiety, depression, mood disorders, insomnia. They also can be the cause of abnormal vital signs, such as tachycardia, increased respiratory rate, and low or elevated blood pressure, and as such, can present a diagnostic challenge and/or be a cause of unnecessary workup in ED.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Karima Sajadi-Ernazarova declares no relevant financial relationships with ineligible companies.

Disclosure: Richard Hamilton declares no relevant financial relationships with ineligible companies.

References

    1. Harstad E, Sideridis G, Sherritt L, Shrier LA, Ziemnik R, Levy S. Concurrent Validity of Caffeine Problems and Diagnostic Criteria for Substance Use Disorders. J Caffeine Res. 2016 Dec 01;6(4):141-147. - PMC - PubMed
    1. Addicott MA. Caffeine Use Disorder: A Review of the Evidence and Future Implications. Curr Addict Rep. 2014 Sep;1(3):186-192. - PMC - PubMed
    1. Stringer KA, Watson WA. Caffeine withdrawal symptoms. Am J Emerg Med. 1987 Sep;5(5):469. - PubMed
    1. Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med. 1992 Oct 15;327(16):1109-14. - PubMed
    1. Meredith SE, Juliano LM, Hughes JR, Griffiths RR. Caffeine Use Disorder: A Comprehensive Review and Research Agenda. J Caffeine Res. 2013 Sep;3(3):114-130. - PMC - PubMed

Publication types

LinkOut - more resources